The USFDA has classified the inspection as an Official Action Indicated (OAI) and issued Form 483 with one observation post ...

Norway’s NBIM, India’s top foreign portfolio investor with $30.5B, slowed bulk buys in 2025, making just two deals. With top ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...

Benchmark equity indices, Sensex and Nifty 50, wrapped up last week on a cautious note, marking a second straight week of ...

Mumbai: Cipla has announced the appointment of Prabhakaran Balakrishnan Nair, presently working as Chief of Quality - Indore ...

Cipla said it will respond to the observation in a timely manner and ensure that the issue pertaining to the observation is ...

Cipla announced that the United States Food and Drug Administration (USFDA) has concluded a current Good Manufacturing Practices (cGMP) inspection at its manufacturing facility in Bommasandra, ...

Stay updated with the Cipla Stock Liveblog, your one-stop destination for real-time information and analysis of a leading ...

The size of India’s insulin market was an estimated Rs 4,404 crore in April this year, with Indian players making steady ...

Several Indian pharmaceutical companies are ushering in the next generation of their promoter families to take over the reins ...

Limited, UK, a wholly owned subsidiary of the Company, has incorporated a new wholly owned subsidiary named 'CiplaRna GmbH' ...

Vodafone Idea, Apollo Hospitals, Coal India, Nykaa, IRB Infrastructure, Spandana Sphoorty Financial, Puravankara, AstraZeneca ...